Telampin S Tablet 40/5 mg
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
MFDS item code 202204035 · Approved 2022.11.08
Treatment of essential hypertension not controlled with monotherapy
This medication effectively helps lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either telmisartan or amlodipine. It is used in the management of essential hypertension to reduce cardiovascular risk and contribute to maintaining healthy blood pressure. Therefore, this drug is used for the treatment of essential hypertension.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or S-amlodipine (amlodipine)); however, direct conversion to this drug may be considered if blood pressure is not controlled with the individual components, as follows. - 40/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this drug 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, for patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
◦ Children: Administration of this drug is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This drug should not be administered to patients with certain conditions, such as severe liver disease, biliary obstructive disorders, severe aortic stenosis, shock, or severe kidney impairment. Patients with low blood pressure, those requiring dialysis due to renal failure, and nursing mothers should also avoid this medication. When administering this drug, extra caution should be exercised in specific situations, such as primary aldosteronism, valvular disease, liver dysfunction, gastrointestinal disease, renal artery hypertension, and elderly patients. Since symptoms of hypotension such as sudden drop in blood pressure or incidents of hyperkalemia or renal function impairment may occur, regular monitoring of blood pressure and blood tests should be conducted. This medication may cause side effects like headache, dizziness, edema, palpitations, and dyspepsia. If these symptoms are severe, consultation with a physician is advised. Elderly patients may react more sensitively to this medication, so dosage should be adjusted, and careful administration is needed. Interactions with other medications may occur; therefore, if currently taking any other medications, it is essential to inform your doctor or pharmacist. If pregnancy is confirmed, discontinue this medication immediately and switch to another safe treatment. Also, it is advisable not to use this drug during breastfeeding. In cases of overdose, symptoms such as hypotension, dizziness, or heart problems may occur, necessitating prompt medical attention. The safety and efficacy of this drug in children have not been adequately established, and it is not recommended for patients under 18 years of age. When storing this drug, it should be kept out of reach of children and not transferred to other containers, as this is crucial for maintaining quality. Caution is required when driving or operating machinery while taking this drug due to potential drowsiness or dizziness.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C. This ensures that the efficacy and safety of the medication are well maintained.
Oblong tablet consisting of two layers, light yellow and light blue
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Healthcare Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
BC World Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.